Cargando…

Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis

Monocytes/macrophages are critical in systemic and local inflammation in giant cell arteritis (GCA) and possibly in clinically overlapping polymyalgia rheumatica (PMR). Therefore, we aimed to understand the contribution of monocyte subsets and the CX3CR1-CX3CL1 and CCR2-CCL2 migratory pathways, to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Sleen, Yannick, Wang, Qi, van der Geest, Kornelis S. M., Westra, Johanna, Abdulahad, Wayel H., Heeringa, Peter, Boots, Annemieke M. H., Brouwer, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529580/ https://www.ncbi.nlm.nih.gov/pubmed/28747747 http://dx.doi.org/10.1038/s41598-017-06826-4

Ejemplares similares

A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL‐40/Interleukin‐13 Receptor α2 Axis
por: van Sleen, Yannick, et al.
Publicado: (2021)

Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?
por: van der Geest, Kornelis S. M., et al.
Publicado: (2018)

Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis
por: van Sleen, Yannick, et al.
Publicado: (2019)

Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2019)

Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2023)

Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment
por: Esen, Idil, et al.
Publicado: (2021)

Distinct macrophage phenotypes skewed by local granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis
por: Jiemy, William F, et al.
Publicado: (2020)

Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8(+) T cells in giant cell arteritis
por: Reitsema, Rosanne D, et al.
Publicado: (2022)

Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis
por: Rondaan, Christien, et al.
Publicado: (2017)

Need and value of targeted immunosuppressive therapy in giant cell arteritis
por: Sandovici, Maria, et al.
Publicado: (2022)

Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA
por: Hid Cadena, Rebeca, et al.
Publicado: (2019)

Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

Monocyte subsets and monocyte-related chemokines in Takayasu arteritis
por: de Aguiar, Mariana Freitas, et al.
Publicado: (2023)

Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients
por: van Nieuwland, Marieke, et al.
Publicado: (2023)

Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort
por: Esen, Idil, et al.
Publicado: (2023)

Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis
por: Esen, Idil, et al.
Publicado: (2021)

Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells
por: van der Geest, Kornelis S. M., et al.
Publicado: (2018)

Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2022)

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply
por: Esen, Idil, et al.
Publicado: (2022)

Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
por: van der Geest, Kornelis S. M., et al.
Publicado: (2022)

Circulating CD4+CD161+ T Lymphocytes Are Increased in Seropositive Arthralgia Patients but Decreased in Patients with Newly Diagnosed Rheumatoid Arthritis
por: Chalan, Paulina, et al.
Publicado: (2013)

Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

Checks and Balances in Autoimmune Vasculitis
por: Hid Cadena, Rebeca, et al.
Publicado: (2018)

CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors?
por: Reitsema, Rosanne D., et al.
Publicado: (2021)

Diagnostic Accuracy of Symptoms, Physical Signs, and Laboratory Tests for Giant Cell Arteritis: A Systematic Review and Meta-analysis
por: van der Geest, Kornelis S. M., et al.
Publicado: (2020)

Quantifying Distribution of Flow Cytometric TCR-Vβ Usage with Economic Statistics
por: van der Geest, Kornelis S. M., et al.
Publicado: (2015)

Effect of age and sex on immune checkpoint expression and kinetics in human T cells
por: Reitsema, Rosanne D., et al.
Publicado: (2020)

The Immunopathology of Giant Cell Arteritis Across Disease Spectra
por: Robinette, Michelle L., et al.
Publicado: (2021)

Massive B-Cell Infiltration and Organization Into Artery Tertiary Lymphoid Organs in the Aorta of Large Vessel Giant Cell Arteritis
por: Graver, Jacoba C., et al.
Publicado: (2019)

Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization
por: Stellingwerff, Menno D., et al.
Publicado: (2015)

Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?
por: Carvajal Alegria, Guillermo, et al.
Publicado: (2023)

Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective
por: Mackie, Sarah L, et al.
Publicado: (2021)

Mucosal-associated invariant T cells in patients with axial spondyloarthritis
por: van der Meer, Rienk Gerben, et al.
Publicado: (2023)

Increased Expression of Toll-Like Receptors by Monocytes and Natural Killer Cells in ANCA-Associated Vasculitis
por: Tadema, Henko, et al.
Publicado: (2011)

Enhanced expression of PD-1 and other activation markers by CD4+ T cells of young but not old patients with metastatic melanoma
por: van den Brom, Rob R. H., et al.
Publicado: (2018)

Regulatory CD4+ T-Cell Subsets and Anti-Citrullinated Protein Antibody Repertoire: Potential Biomarkers for Arthritis Development in Seropositive Arthralgia Patients?
por: Janssen, Koen M. J., et al.
Publicado: (2016)

Role of the halo sign in the assessment of giant cell arteritis: a systematic review and meta-analysis
por: Sebastian, Alwin, et al.
Publicado: (2021)

Low-affinity TCR engagement drives IL-2-dependent post-thymic maintenance of naive CD4+ T cells in aged humans
por: van der Geest, Kornelis S M, et al.
Publicado: (2015)

Proportions of B-cell subsets are altered in incomplete systemic lupus erythematosus and correlate with interferon score and IgG levels
por: Henning, Svenja, et al.
Publicado: (2020)

Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica
por: van der Geest, Kornelis S M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a0juikc0oues544dolqohi1lb8